FOCAL POINTS (Courageous Discourse)

FOCAL POINTS (Courageous Discourse)

Prevalence of Statin Intolerance: a Meta-analysis

Frequently Recommended Drugs Hit Brick Wall of Perceived Intolerance

Peter A. McCullough, MD, MPH's avatar
Peter A. McCullough, MD, MPH
Jul 10, 2024
∙ Paid
Upgrade to paid to play voiceover

By Peter A. McCullough, MD, MPH

Hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors, also known as "statins," are used adjunctively to diet and exercise to treat hypercholesterolemia by lowering total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) concentrations resulting in ~20% and ~30% reductions in atherosclerotic cardiovascular disease outcomes at 2 years in those without and with baseline disease. This month, simvastatin will be available over-the-counter in the United Kingdom as other countries have allowed OTC sales for years.

I often find resistance among prospective patients who have never taken a tablet because they anticipate they will have problems including muscle aches. But how common is this problem?

User's avatar

Continue reading this post for free, courtesy of Peter A. McCullough, MD, MPH.

Or purchase a paid subscription.
© 2026 Peter McCullough MD MPH · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture